Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 2/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL412030 | 0.83 | TSHR (0.61) | MAOAMAOBTSHRFFAR1HDAC1 | |
| SCHEMBL7265672 | 0.82 | TSHR (0.55) | TSHRALDH1A1HPGDALOX15ALOX12 | |
| SCHEMBL6824408 | 0.82 | TSHR (0.55) | TSHRALDH1A1HPGDALOX15ALOX12 | |
| Benzene SCHEMBL3440179 | 0.82 | ALDH1A1 (0.69) | MAOAMAOBFFAR1ALDH1A1HPGD | |
| SCHEMBL62125 | 0.82 | ALDH1A1 (0.69) | MAOAMAOBFFAR1ALDH1A1HPGD | |
| SCHEMBL9741303 | 0.82 | ALDH1A1 (0.69) | MAOAMAOBFFAR1ALDH1A1HPGD | |
| SCHEMBL1041355 | 0.79 | ALDH1A1 (0.58) | MAOAMAOBFFAR1ALDH1A1HPGD | |
| SCHEMBL7136305 | 0.79 | ALDH1A1 (0.58) | MAOAMAOBFFAR1ALDH1A1HPGD | |
| SCHEMBL8371905 | 0.79 | TSHR (0.57) | TSHRFFAR1HPGDHDAC1KEAP1 | |
| SCHEMBL10453073 | 0.79 | TSHR (0.52) | MAOAMAOBTSHRHDAC1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119463391-A | High-strength flame-retardant plastic-wood board and manufacturing process thereof | 美新科技股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-109384959-B | Preparation method of phosphorus-nitrogen high-load hydrotalcite flame retardant | 台州职业技术学院 | 2020-06-09 | — | — | CN | claimed |
| CN-119463391-A | High-strength flame-retardant plastic-wood board and manufacturing process thereof | 美新科技股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20240279220-A1 | INDOLE COMPOUNDS AND METHODS OF USE | SIONNA THERAPEUTICS INC. | 2024-08-22 | — | — | US | disclosed |
| EP-4396179-A1 | INDOLE COMPOUNDS AND METHODS OF USE | GENZYME CORPORATION (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2023034992-A1 | INDOLE COMPOUNDS AND METHODS OF USE | GENZYME CORPORATION (US) | 2023-03-09 | — | — | WO | disclosed |
| CN-112500441-A | Preparation process of high-purity glycosyl phosphate | 上海彩迩文生化科技有限公司 | 2021-03-16 | — | — | CN | disclosed |
| CN-106349217-B | Serine/threonine kinase inhibitors | 阵列生物制药公司 | 2020-08-28 | — | — | CN | disclosed |
| CN-109384959-B | Preparation method of phosphorus-nitrogen high-load hydrotalcite flame retardant | 台州职业技术学院 | 2020-06-09 | — | — | CN | disclosed |
| EP-2564834-A2 | Compounds for Proteasome Enzyme Inhibition | Onyx Therapeutics, Inc. (US) | 2013-03-06 | — | — | EP | disclosed |
| US-20120101025-A1 | Compounds For Enzyme Inhibition | ONYX THERAPEUTICS, INC. (US) | 2012-04-26 | — | — | US | disclosed |
| US-5614550-A | ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | disclosed |
| EP-0632036-A2 | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1995-01-04 | — | — | EP | disclosed |
| CN-1024668-C | Preparation method of 2- (2-isoxazolidinyl) -2-tetrahydrofuran carboxylic acid derivative | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1994-05-25 | — | — | CN | disclosed |
| US-4788215-A | TREATMENT OF HYPERTHYROIDISM | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-11-29 | — | — | US | disclosed |
| EP-0278501-A2 | Nucleotide analogs, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1988-08-17 | — | — | EP | disclosed |
| US-4713465-A | Flavanone intermediates for halogenohydroxyflavones | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1987-12-15 | — | — | US | disclosed |
| CN-85109633-A | Process for the preparation of antibiotic derivatives | — | 1987-01-07 | — | — | CN | disclosed |
| US-4165312-A | TRYPTOPHANE-ALANINE-GLYCINE OR ALANINE-GLYCINE OR ALANINE-ASPARTIC ACID-ALANINE-SERINE(PHOSPHATE)-GLYCINE OR ALANINE-GLUTAMIC ACID, SLEEP INDUCERS | HOFFMANN-LA ROCHE INC. (US) | 1979-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279220-A1 | INDOLE COMPOUNDS AND METHODS OF USE | CFTR, INMT, IDO1 | MAOA 139/4885MAOB 103/4885TSHR 2973/4885 |
| US-20120101025-A1 | Compounds For Enzyme Inhibition | ANPEP, DNPEP, CPN1 | MAOA 546/4885MAOB 690/4885TSHR 2765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.